Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T08:10:15.966Z Has data issue: false hasContentIssue false
  • English
  • Français

Chairman's concluding remarks

Published online by Cambridge University Press:  06 April 2009

Bridget M. Ogilvie
Bridget M. Ogilvie
Affiliation:
The Wellcome Trust, I Park Square West, London NW1 4LJ
Get access Rights & Permissions [Opens in a new window]

Summary

This meeting included talks which covered both the principles and problems of vaccine development and others that extensively reviewed the present state of progress towards the goal of antigenically defined parasite vaccines for human and veterinary use. Several speakers, particularly Drs Morrison and Gutteridge, pointed out that in comparison with bacteria and viruses there are few vaccines available against parasites and these consist of attenuated organisms for veterinary infections. Therefore, despite the intensity of effort, better defined vaccines for parasites still elude us.

Type
Research Article
Information
Parasitology , Volume 98 , supplement S1: Symposia of the British Society for Parasitology Volume 26:Vaccines and vaccination strategies , January 1989 , pp. S99 - S100
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Ogilvie, B. M. (1988). Vaccines: around which corner? Immunology Letters 19, 245–50.CrossRefGoogle ScholarPubMed
Williams, J. F. (1986). Prospects for prophylaxis of parasitism. In Parasitology – Quo Vadit? (ed. Howell, M. J.), pp. 711–719. Canberra: Australian Academy of Science.Google Scholar
De Wilde, M. (1987). Vaccine development within industry. Acta Tropica 44, Suppl.12, 104–7.Google Scholar